Detailed information for compound 149023

Basic information

Technical information
  • TDR Targets ID: 149023
  • Name: 2-phenyl-3-(2-piperidin-1-ylethyl)-1H-indole
  • MW: 304.429 | Formula: C21H24N2
  • H donors: 1 H acceptors: 0 LogP: 4.85 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: C1CCN(CC1)CCc1c([nH]c2c1cccc2)c1ccccc1
  • InChi: 1S/C21H24N2/c1-3-9-17(10-4-1)21-19(13-16-23-14-7-2-8-15-23)18-11-5-6-12-20(18)22-21/h1,3-6,9-12,22H,2,7-8,13-16H2
  • InChiKey: FKIIRAHSARSGPF-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-phenyl-3-[2-(1-piperidyl)ethyl]-1H-indole
  • 2-phenyl-3-(2-piperidinoethyl)-1H-indole

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled Starlite/ChEMBL References
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled Starlite/ChEMBL References
Homo sapiens dopamine receptor D2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi Serotonin receptor Get druggable targets OG5_135430 All targets in OG5_135430

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) PAN domain-containing protein 0.0018 0.0157 0.1224
Schistosoma mansoni hypothetical protein 0.0023 0.0247 0.1919
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Loa Loa (eye worm) hypothetical protein 0.0081 0.1285 1
Echinococcus granulosus fatty acid amide hydrolase 1 0.0081 0.1285 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0055 0.0824 1
Mycobacterium leprae POSSIBLE LYSOPHOSPHOLIPASE 0.0055 0.0824 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Echinococcus multilocularis SWI:SNF matrix associated 0.0023 0.0247 0.1919
Plasmodium falciparum esterase, putative 0.0055 0.0824 1
Loa Loa (eye worm) PAN domain-containing protein 0.0018 0.0157 0.1224
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.0023 0.0247 0.1919
Brugia malayi brahma associated protein 60 kDa 0.0023 0.0247 0.0247
Mycobacterium ulcerans lysophospholipase 0.0055 0.0824 1
Chlamydia trachomatis DNA topoisomerase I 0.0023 0.0247 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0055 0.0824 1
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.0023 0.0247 0.0184
Mycobacterium tuberculosis Possible lysophospholipase 0.0055 0.0824 1
Mycobacterium ulcerans hypothetical protein 0.0055 0.0824 1
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Plasmodium falciparum lysophospholipase, putative 0.0055 0.0824 1
Loa Loa (eye worm) brahma associated protein 0.0023 0.0247 0.1919
Echinococcus granulosus fatty acid amide hydrolase 1 0.0081 0.1285 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0055 0.0824 1
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Treponema pallidum aspartyl/glutamyl-tRNA amidotransferase subunit A 0.001 0 0.5
Leishmania major monoglyceride lipase, putative 0.0055 0.0824 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0023 0.0247 0.1919
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0055 0.0824 0.5
Echinococcus granulosus Upstream activation factor subunit UAF30 0.0023 0.0247 0.1919
Schistosoma mansoni fatty-acid amide hydrolase 0.0081 0.1285 1
Schistosoma mansoni amidase 0.0081 0.1285 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Schistosoma mansoni brg-1 associated factor 0.0023 0.0247 0.1919
Trichomonas vaginalis conserved hypothetical protein 0.0055 0.0824 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0023 0.0247 0.2994
Trypanosoma cruzi monoglyceride lipase, putative 0.0055 0.0824 1
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0081 0.1285 1
Trichomonas vaginalis conserved hypothetical protein 0.0055 0.0824 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Onchocerca volvulus 0.0023 0.0247 1
Wolbachia endosymbiont of Brugia malayi aspartyl/glutamyl-tRNA amidotransferase subunit A 0.001 0 0.5
Brugia malayi SWIB/MDM2 domain containing protein 0.0023 0.0247 0.0247
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Echinococcus multilocularis SWI:SNF matrix associated 0.0023 0.0247 0.1919
Brugia malayi brahma associated protein 60 kDa 0.0023 0.0247 0.0247
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0081 0.1285 1
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0055 0.0824 0.5
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.0023 0.0247 0.2994
Trypanosoma brucei monoglyceride lipase, putative 0.0055 0.0824 1
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0055 0.0824 1
Plasmodium falciparum lysophospholipase, putative 0.0055 0.0824 1
Chlamydia trachomatis SWIB complex protein 0.0023 0.0247 1
Trichomonas vaginalis valacyclovir hydrolase, putative 0.0055 0.0824 1
Plasmodium falciparum lysophospholipase, putative 0.0055 0.0824 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Brugia malayi amidase 0.0081 0.1285 0.1285
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Trypanosoma brucei monoglyceride lipase, putative 0.0055 0.0824 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0055 0.0824 1
Echinococcus granulosus SWI:SNF matrix associated 0.0023 0.0247 0.1919
Loa Loa (eye worm) PAN domain-containing protein 0.0018 0.0157 0.1224
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0023 0.0247 0.2994
Schistosoma mansoni hypothetical protein 0.0023 0.0247 0.1919
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.0023 0.0247 0.0184
Loa Loa (eye worm) PAN domain-containing protein 0.0018 0.0157 0.1224
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Toxoplasma gondii PAN domain-containing protein 0.0287 0.5007 1
Brugia malayi PAN domain containing protein 0.0018 0.0157 0.0157
Plasmodium vivax hypothetical protein, conserved 0.0023 0.0247 0.2994
Schistosoma mansoni hypothetical protein 0.0023 0.0247 0.1919
Loa Loa (eye worm) hypothetical protein 0.0018 0.0157 0.1224
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.0023 0.0247 0.1919
Loa Loa (eye worm) PAN domain-containing protein 0.0018 0.0157 0.1224
Toxoplasma gondii PAN domain-containing protein 0.0287 0.5007 1
Plasmodium vivax PST-A protein 0.0055 0.0824 1

Activities

Activity type Activity value Assay description Source Reference
F (ADMET) < 5 % Oral bioavailability in rat ChEMBL. 11133072
Ki (binding) = 2.6 nM Displacent of [H]-ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor. ChEMBL. 11133071
Ki (binding) = 2.6 nM Displacent of [H]-ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor. ChEMBL. 11133071
Ki (binding) = 2.7 nM Displacement of [3H]-ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells ChEMBL. 11133072
Ki (binding) = 2.7 nM Ability of the compound to displace [H]-ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined ChEMBL. 11133070
Ki (binding) = 2.7 nM Displacement of [3H]-ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells ChEMBL. 11133072
Ki (binding) = 2.7 nM Ability of the compound to displace [H]-ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined ChEMBL. 11133070
Ki (binding) = 268 nM Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor. ChEMBL. 11133071
Ki (binding) = 268 nM Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor. ChEMBL. 11133071
Ki (binding) = 896 nM Displacement of [3H]-spiperone from CHO cells expressing human Dopamine receptor D2. ChEMBL. 11133071
Ki (binding) = 896 nM Displacement of [3H]-spiperone from CHO cells expressing human Dopamine receptor D2. ChEMBL. 11133071
Ki (binding) = 900 nM Ability of the compound to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined ChEMBL. 11133070
Ki (binding) = 900 nM Ability of the compound to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined ChEMBL. 11133070
Ratio (binding) = 100 Selectivity as ratio of Ki against human 5-HT2C and 5-HT2A receptors ChEMBL. 11133072
Ratio (binding) = 330 Selectivity as ratio of Ki against human dopamine D2 and 5-HT2A receptors ChEMBL. 11133072

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

3 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.